bioRxiv / medRxivopen access
ASXL3 truncating patient variants mediate transcriptional gain-of-function and are antisense oligonucleotide-responsive
genetic and genomic medicine
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 471398
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.